Halozyme Therapeutics Inc... (HALO)
NASDAQ: HALO
· Real-Time Price · USD
67.02
1.48 (2.26%)
At close: Aug 15, 2025, 12:48 PM
Halozyme Therapeutics Fail-to-Deliver
Total FTD Shares
53
Below Average
FTD / Avg. Volume
< 0.01%
Low Impact
1-Year Change
-97.9%
Negative Trend
FTD Chart
As of Jul 14, 2025,
Halozyme Therapeutics Inc. has
53
shares failed to deliver, representing 0.00%
of the average daily volume of
2,376,241.5
shares. Over the past year, the monthly average FTD is
7,477
shares, with the current level 99% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jul 14, 2025 | 57.65 | 53 | -99.78% |
Jun 23, 2025 | 52.8 | 24.54K | -59.04% |
May 30, 2025 | 56.07 | 59.9K | +140.38% |
Apr 25, 2025 | 60.49 | 24.92K | +290.30% |
Mar 27, 2025 | 64.48 | 6.38K | -53.71% |
Feb 19, 2025 | 57.77 | 13.79K | +4169.97% |
Jan 30, 2025 | 56.42 | 323 | -99.38% |
Dec 31, 2024 | 47.81 | 52.15K | +5204.68% |
Nov 29, 2024 | 48.2 | 983 | +1070.24% |
Oct 29, 2024 | 50.64 | 84 | -99.27% |
Sep 26, 2024 | 56.95 | 11.45K | +2574.53% |
Aug 29, 2024 | 63.74 | 428 | +970.00% |
Jul 30, 2024 | 55.69 | 40 | -97.29% |
Jun 26, 2024 | 52 | 1.48K | -80.30% |
May 22, 2024 | 45.48 | 7.49K | +1193.26% |
Apr 11, 2024 | 39.32 | 579 | -85.74% |
Mar 27, 2024 | 40.73 | 4.06K | +423.20% |
Feb 29, 2024 | 39.81 | 776 | -20.41% |
Jan 26, 2024 | 34.21 | 975 | +12.46% |
Dec 27, 2023 | 36.9 | 867 | -96.52% |
Nov 16, 2023 | 39.52 | 24.9K | +2925.52% |
Oct 23, 2023 | 34.77 | 823 | -73.43% |
Sep 29, 2023 | 38.2 | 3.1K | -96.04% |
Aug 09, 2023 | 42.63 | 78.14K | +2789.68% |
Jul 31, 2023 | 42.96 | 2.7K | +216.26% |
Jun 29, 2023 | 34.67 | 855 | -11.31% |
May 31, 2023 | 32.43 | 964 | +6.28% |
Apr 28, 2023 | 32.13 | 907 | -98.66% |
Mar 31, 2023 | 38.19 | 67.92K | +7815.62% |
Feb 28, 2023 | 47.99 | 858 | -93.29% |
Jan 31, 2023 | 51.77 | 12.78K | n/a |